EDAP TMS SA - 8-K Filing
EDAP TMS SA (trading as FocalTherics) held an Investor Day presentation on June 1, 2026, outlining its transformation into a robotic focal therapy company focused on prostate cancer and other indications. The company highlighted HIFU revenue growth of +32% CAGR over three years and plans to discontinue non-core ESWL and Distribution segments in Q2 CY26. (Items: 9.01 of this Form 8-K, including Exhibit 99)
Tickers: $EDAP